206 related articles for article (PubMed ID: 22714142)
1. Hypoxia-induced tumor cell autophagy mediates resistance to anti-angiogenic therapy.
Hu YL; Jahangiri A; De Lay M; Aghi MK
Autophagy; 2012 Jun; 8(6):979-81. PubMed ID: 22714142
[TBL] [Abstract][Full Text] [Related]
2. Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies.
Rapisarda A; Melillo G
Drug Resist Updat; 2009 Jun; 12(3):74-80. PubMed ID: 19394890
[TBL] [Abstract][Full Text] [Related]
3. Autophagy as a mechanism for anti-angiogenic therapy resistance.
Chandra A; Rick J; Yagnik G; Aghi MK
Semin Cancer Biol; 2020 Nov; 66():75-88. PubMed ID: 31472232
[TBL] [Abstract][Full Text] [Related]
4. The Sabotaging Role of Myeloid Cells in Anti-Angiogenic Therapy: Coordination of Angiogenesis and Immune Suppression by Hypoxia.
Li C; Liu T; Bazhin AV; Yang Y
J Cell Physiol; 2017 Sep; 232(9):2312-2322. PubMed ID: 27935039
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
Rohwer N; Cramer T
Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
[TBL] [Abstract][Full Text] [Related]
6. Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors.
Kes MMG; Van den Bossche J; Griffioen AW; Huijbers EJM
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188427. PubMed ID: 32961257
[TBL] [Abstract][Full Text] [Related]
7. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
8. [Angiogenic inhibitors and radiotherapy: from the concept to the clinical trial].
Cohen-Jonathan Moyal E
Cancer Radiother; 2009 Oct; 13(6-7):562-7. PubMed ID: 19695923
[TBL] [Abstract][Full Text] [Related]
9. Rhaponticin decreases the metastatic and angiogenic abilities of cancer cells via suppression of the HIF‑1α pathway.
Kim A; Ma JY
Int J Oncol; 2018 Sep; 53(3):1160-1170. PubMed ID: 30015877
[TBL] [Abstract][Full Text] [Related]
10. Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentiality.
McIntyre A; Harris AL
EMBO Mol Med; 2015 Apr; 7(4):368-79. PubMed ID: 25700172
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma.
Hu YL; DeLay M; Jahangiri A; Molinaro AM; Rose SD; Carbonell WS; Aghi MK
Cancer Res; 2012 Apr; 72(7):1773-83. PubMed ID: 22447568
[TBL] [Abstract][Full Text] [Related]
12. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy.
Abdollahi A; Folkman J
Drug Resist Updat; 2010; 13(1-2):16-28. PubMed ID: 20061178
[TBL] [Abstract][Full Text] [Related]
13. Autophagy, a double-edged sword in anti-angiogenesis therapy.
Liu J; Fan L; Wang H; Sun G
Med Oncol; 2016 Jan; 33(1):10. PubMed ID: 26715036
[TBL] [Abstract][Full Text] [Related]
14. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
Shojaei F; Ferrara N
Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
[TBL] [Abstract][Full Text] [Related]
15. Tumor cell autophagy as an adaptive response mediating resistance to treatments such as antiangiogenic therapy.
Hu YL; Jahangiri A; Delay M; Aghi MK
Cancer Res; 2012 Sep; 72(17):4294-9. PubMed ID: 22915758
[TBL] [Abstract][Full Text] [Related]
16. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
Erin N; Grahovac J; Brozovic A; Efferth T
Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-associated autophagy flux dysregulation in human cancers.
Fu J; Lin J; Dai Z; Lin B; Zhang J
Cancer Lett; 2024 May; 590():216823. PubMed ID: 38521197
[TBL] [Abstract][Full Text] [Related]
18. Metabolic effects of anti-angiogenic therapy in tumors.
Zulato E; Curtarello M; Nardo G; Indraccolo S
Biochimie; 2012 Apr; 94(4):925-31. PubMed ID: 22245704
[TBL] [Abstract][Full Text] [Related]
19. Why do tumors become resistant to antiangiogenesis drugs?
Schmidt C
J Natl Cancer Inst; 2009 Nov; 101(22):1530-2. PubMed ID: 19880813
[No Abstract] [Full Text] [Related]
20. Tumour angiogenesis, anti-angiogenic therapy and chemotherapeutic resistance.
Mander KA; Finnie JW
Aust Vet J; 2018 Oct; 96(10):371-378. PubMed ID: 30255577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
